P017 C86/CD16 macrophages accumulate in the mucosa of B3 patients and could mediate EMT in Crohn’s disease
ECCO'20 Vienna
2020
P018 Per- and polyfluoroalkyl substances (PFAS) are significantly increased in patients with late-onset of ulcerative colitis
ECCO'20 Vienna
2020
P019 Colonic mucosal kinase activity, cytokine and chemokine profiles in inflammatory bowel disease
ECCO'20 Vienna
2020
P020 MAM, an anti-inflammatory protein derived from Faecalibacterium prausnitzii as a biomarker in Crohn’s disease?
ECCO'20 Vienna
2020
P021 The influence of short-chain fatty acids produced by commensal bacteria on macrophage phenotype
ECCO'20 Vienna
2020
P023 Identification of regulated mechanistic pathways and genes to protect intestinal barrier injury by larazotide acetate in an IBD microenvironment
ECCO'20 Vienna
2020
P024 Evaluation of the clinical course of patients diagnosed with primary sclerosing cholangitis: single centre study
ECCO'20 Vienna
2020
P025 Evaluation of endoplasmic reticulum stress in intestinal mucosa from patients with Crohn’s disease
ECCO'20 Vienna
2020
P026 The impact of different dietary factors in the etiopathogenesis of inflammatory bowel disease: a retrospective case–control study
ECCO'20 Vienna
2020
P027 Repertoire analysis of memory T-cell receptors in Japanese patients with inflammatory bowel disease
ECCO'20 Vienna
2020
P029 TRIM 21 protects against ulcerative colitis and colitic cancer via smad7 inhibition
ECCO'20 Vienna
2020
P030 Dynamics of intestinal inflammation and microbial dysbiosis in pregnant women with IBD and their infants
ECCO'20 Vienna
2020
P031 Therapeutic effect of OPS-2071 in a murine model of Crohn’s disease and in in vitro anti-inflammatory assays
ECCO'20 Vienna
2020
P033 Combination of vedolizumab with tacrolimus is more efficient in reducing intestinal inflammation than vedolizumab alone in the DSS-induced acute colitis mouse model
ECCO'20 Vienna
2020